MINA, Roberto
MINA, Roberto
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma
2021-01-01 Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P.
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study
2022-01-01 Visco C.; Marcheselli L.; Mina R.; Sassone M.; Guidetti A.; Penna D.; Cattaneo C.; Bonuomo V.; Busca A.; Ferreri A.J.M.; Bruna R.; Petrucci L.; Cairoli R.; Salvini M.; Bertu L.; Ladetto M.; Pilerci S.; Pinto A.; Ramadan S.; Marchesi F.; Cavo M.; Arcaini L.; Coviello E.; Romano A.; Musto P.; Massaia M.; Fracchiolla N.; Marchetti M.; Scattolin A.; Tisi M.C.; Cuneo A.; Porta M.D.; Trentin L.; Turrini M.; Gherlinzoni F.; Tafuri A.; Galimberti S.; Bocchia M.; Cardinali V.; Cilloni D.; Corso A.; Armiento D.; Rigacci L.; La Barbera E.O.; Gambacorti-Passerini C.; Visani G.; Vallisa D.; Venditti A.; Selleri C.; Conconi A.; Tosi P.; Lanza F.; Candoni A.; Krampera M.; Corradini P.; Passamonti F.; Merli F.
A prospective, multicenter study on hematopoietic stem-cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents
2023-01-01 Mina, Roberto; Petrucci, Maria Teresa; Bonello, Francesca; Bongarzoni, Velia; Saccardi, Riccardo; Bertuglia, Giuseppe; Mengarelli, Andrea; Spadaro, Andrea; Lisi, Chiara; Curci, Paola; Lemoli, Roberto Massimo; Ballanti, Stelvio; Floris, Rita; Cupelli, Luca; Tosi, Patrizia; Olivieri, Attilio; Rota-Scalabrini, Delia; Cangialosi, Clotilde; Nozzoli, Chiara; Anaclerico, Barbara; Fazio, Francesca; Bruno, Benedetto; Mancuso, Katia; Corradini, Paolo; Milone, Giuseppe; Boccadoro, Mario
Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors
2022-01-01 Boccalatte, Francesco; Mina, Roberto; Aroldi, Andrea; Leone, Sarah; Suryadevara, Carter M; Placantonakis, Dimitris G; Bruno, Benedetto
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials
2013-01-01 Bringhen S;Mateos MV;Zweegman S;Larocca A;Falcone AP;Oriol A;Rossi D;Cavalli M;Wijermans P;Ria R;Offidani M;Lahuerta JJ;Liberati AM;Mina R;Callea V;Schaafsma M;Cerrato C;Marasca R;Franceschini L;Evangelista A;Teruel AI;van der Holt B;Montefusco V;Ciccone G;Boccadoro M;San Miguel J;Sonneveld P;Palumbo A
Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen?
2020-01-01 D'Agostino M.; Mina R.; Gay F.
Antibody-drug conjugates: when chemotherapy meets immuno-oncology
2021-01-01 Mina R.; Gay F.
Approach to the Older Adult With Multiple Myeloma
2019-01-01 Mina, Roberto; Bringhen, Sara; Wildes, Tanya M; Zweegman, Sonja; Rosko, Ashley E
Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study
2020-01-01 Mina R.; Belotti A.; Petrucci M.T.; Zambello R.; Capra A.; Di Lullo G.; Ronconi S.; Pescosta N.; Grasso M.; Monaco F.; Cellini C.; Gobbi M.; Ballanti S.; de Fabritiis P.; Mosca-Siez M.L.; Marchetti M.; Liberati A.M.; Offidani M.; Giuliani N.; Ria R.; Musto P.; Romano A.; Sonneveld P.; Boccadoro M.; Larocca A.
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival.
2014-01-01 Palumbo A;Bringhen S;Larocca A;Rossi D;Di Raimondo F;Magarotto V;Patriarca F;Levi A;Benevolo G;Vincelli ID;Grasso M;Franceschini L;Gottardi D;Zambello R;Montefusco V;Falcone AP;Omedé P;Marasca R;Morabito F;Mina R;Guglielmelli T;Nozzoli C;Passera R;Gaidano G;Offidani M;Ria R;Petrucci MT;Musto P;Boccadoro M;Cavo M
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
2023-01-01 Mina, Roberto; Musto, Pellegrino; Rota-Scalabrini, Delia; Paris, Laura; Gamberi, Barbara; Palmas, Angelo; Aquino, Sara; de Fabritiis, Paolo; Giuliani, Nicola; De Rosa, Luca; Gozzetti, Alessandro; Cellini, Claudia; Bertamini, Luca; Capra, Andrea; Oddolo, Daniela; Vincelli, Iolanda Donatella; Ronconi, Sonia; Pavone, Vincenzo; Pescosta, Norbert; Cea, Michele; Fioritoni, Francesca; Ballanti, Stelvio; Grasso, Mariella; Zamagni, Elena; Belotti, Angelo; Boccadoro, Mario; Gay, Francesca
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies
2021-01-01 Mina, Roberto; Bonello, Francesca; Petrucci, Maria Teresa; Liberati, Anna Marina; Conticello, Concetta; Ballanti, Stelvio; Musto, Pellegrino; Olivieri, Attilio; Benevolo, Giulia; Capra, Andrea; Gilestro, Milena; Galieni, Piero; Cavo, Michele; Siniscalchi, Agostina; Palumbo, Antonio; Montefusco, Vittorio; Gaidano, Gianluca; Omedé, Paola; Boccadoro, Mario; Bringhen, Sara
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
2020-01-01 Mina R.; Joseph N.S.; Gay F.; Kastritis E.; Petrucci M.T.; Kaufman J.L.; Montefusco V.; Gavriatopoulou M.; Patriarca F.; Omede P.; Boise L.H.; Roussou M.; Giuliani N.; Oliva S.; Offidani M.; Belotti A.; Jaye D.L.; De Paoli L.; Terpos E.; Lonial S.; Boccadoro M.; Nooka A.K.; Dimopoulos M.A.
Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study
2019-01-01 Kaufman J.L.; Mina R.; Jakubowiak A.J.; Zimmerman T.L.; Wolf J.J.; Lewis C.; Gleason C.; Sharp C.; Martin T.; Heffner L.T.; Nooka A.K.; Harvey R.D.; Lonial S.
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies
2021-01-01 Passamonti F.; Romano A.; Salvini M.; Merli F.; Porta M.G.D.; Bruna R.; Coviello E.; Romano I.; Cairoli R.; Lemoli R.; Farina F.; Venditti A.; Busca A.; Ladetto M.; Massaia M.; Pinto A.; Arcaini L.; Tafuri A.; Marchesi F.; Fracchiolla N.; Bocchia M.; Armiento D.; Candoni A.; Krampera M.; Luppi M.; Cardinali V.; Galimberti S.; Cattaneo C.; La Barbera E.O.; Mina R.; Lanza F.; Visani G.; Musto P.; Petrucci L.; Zaja F.; Grossi P.A.; Bertu L.; Pagano L.; Corradini P.; Derenzini E.; Marchetti M.; Scattolin A.M.; Corso A.; Tosi P.; Gherlinzoni F.; Passerini C.G.; Cavo M.; Fava C.; Turrini M.; Visco C.; Zappasodi P.; Merli M.; Mora B.; Vannucchi A.M.
Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma
2014-01-01 Bringhen S.; Gay F.; Donato F.; Troia R.; Mina R.; Palumbo A.
Current treatment strategies with lenalidomide in multiple myeloma and future perspectives.
2012-01-01 Larocca A;Cavallo F;Mina R;Boccadoro M;Palumbo A
CyTOF®: A New Tool to Decipher the Immunomodulatory Activity of Daratumumab
2019-01-01 Castella B, Mina R, Gay F
Daratumumab-Based Therapy for IgM Multiple Myeloma With Hyperviscosity Syndrome: A Case Report
2021-01-01 Mina R.; Bonello F.; Gay F.; Zamagni E.; Boccadoro M.
Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients
2021-01-01 Zaccaria, Gian Maria; Bertamini, Luca; Petrucci, Maria Teresa; Offidani, Massimo; Corradini, Paolo; Capra, Andrea; Romano, Alessandra; Liberati, Anna Marina; Mannina, Donato; de Fabritiis, Paolo; Cascavilla, Nicola; Ruggeri, Marina; Mina, Roberto; Patriarca, Francesca; Benevolo, Giulia; Belotti, Angelo; Gaidano, Gianluca; Nagler, Arnon; Hájek, Roman; Spencer, Andrew; Sonneveld, Pieter; Musto, Pellegrino; Boccadoro, Mario; Gay, Francesca
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma | 2021 | Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P. | |
| A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study | 2022 | Visco C.; Marcheselli L.; Mina R.; Sassone M.; Guidetti A.; Penna D.; Cattaneo C.; Bonuomo V.; Busca A.; Ferreri A.J.M.; Bruna R.; Petrucci L.; Cairoli R.; Salvini M.; Bertu L.; Ladetto M.; Pilerci S.; Pinto A.; Ramadan S.; Marchesi F.; Cavo M.; Arcaini L.; Coviello E.; Romano A.; Musto P.; Massaia M.; Fracchiolla N.; Marchetti M.; Scattolin A.; Tisi M.C.; Cuneo A.; Porta M.D.; Trentin L.; Turrini M.; Gherlinzoni F.; Tafuri A.; Galimberti S.; Bocchia M.; Cardinali V.; Cilloni D.; Corso A.; Armiento D.; Rigacci L.; La Barbera E.O.; Gambacorti-Passerini C.; Visani G.; Vallisa D.; Venditti A.; Selleri C.; Conconi A.; Tosi P.; Lanza F.; Candoni A.; Krampera M.; Corradini P.; Passamonti F.; Merli F. | |
| A prospective, multicenter study on hematopoietic stem-cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents | 2023 | Mina, Roberto; Petrucci, Maria Teresa; Bonello, Francesca; Bongarzoni, Velia; Saccardi, Riccardo; Bertuglia, Giuseppe; Mengarelli, Andrea; Spadaro, Andrea; Lisi, Chiara; Curci, Paola; Lemoli, Roberto Massimo; Ballanti, Stelvio; Floris, Rita; Cupelli, Luca; Tosi, Patrizia; Olivieri, Attilio; Rota-Scalabrini, Delia; Cangialosi, Clotilde; Nozzoli, Chiara; Anaclerico, Barbara; Fazio, Francesca; Bruno, Benedetto; Mancuso, Katia; Corradini, Paolo; Milone, Giuseppe; Boccadoro, Mario | |
| Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors | 2022 | Boccalatte, Francesco; Mina, Roberto; Aroldi, Andrea; Leone, Sarah; Suryadevara, Carter M; Placantonakis, Dimitris G; Bruno, Benedetto | |
| Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials | 2013 | Bringhen S;Mateos MV;Zweegman S;Larocca A;Falcone AP;Oriol A;Rossi D;Cavalli M;Wijermans P;Ria R;Offidani M;Lahuerta JJ;Liberati AM;Mina R;Callea V;Schaafsma M;Cerrato C;Marasca R;Franceschini L;Evangelista A;Teruel AI;van der Holt B;Montefusco V;Ciccone G;Boccadoro M;San Miguel J;Sonneveld P;Palumbo A | |
| Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen? | 2020 | D'Agostino M.; Mina R.; Gay F. | |
| Antibody-drug conjugates: when chemotherapy meets immuno-oncology | 2021 | Mina R.; Gay F. | |
| Approach to the Older Adult With Multiple Myeloma | 2019 | Mina, Roberto; Bringhen, Sara; Wildes, Tanya M; Zweegman, Sonja; Rosko, Ashley E | |
| Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study | 2020 | Mina R.; Belotti A.; Petrucci M.T.; Zambello R.; Capra A.; Di Lullo G.; Ronconi S.; Pescosta N.; Grasso M.; Monaco F.; Cellini C.; Gobbi M.; Ballanti S.; de Fabritiis P.; Mosca-Siez M.L.; Marchetti M.; Liberati A.M.; Offidani M.; Giuliani N.; Ria R.; Musto P.; Romano A.; Sonneveld P.; Boccadoro M.; Larocca A. | |
| Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival. | 2014 | Palumbo A;Bringhen S;Larocca A;Rossi D;Di Raimondo F;Magarotto V;Patriarca F;Levi A;Benevolo G;Vincelli ID;Grasso M;Franceschini L;Gottardi D;Zambello R;Montefusco V;Falcone AP;Omedé P;Marasca R;Morabito F;Mina R;Guglielmelli T;Nozzoli C;Passera R;Gaidano G;Offidani M;Ria R;Petrucci MT;Musto P;Boccadoro M;Cavo M | |
| Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial | 2023 | Mina, Roberto; Musto, Pellegrino; Rota-Scalabrini, Delia; Paris, Laura; Gamberi, Barbara; Palmas, Angelo; Aquino, Sara; de Fabritiis, Paolo; Giuliani, Nicola; De Rosa, Luca; Gozzetti, Alessandro; Cellini, Claudia; Bertamini, Luca; Capra, Andrea; Oddolo, Daniela; Vincelli, Iolanda Donatella; Ronconi, Sonia; Pavone, Vincenzo; Pescosta, Norbert; Cea, Michele; Fioritoni, Francesca; Ballanti, Stelvio; Grasso, Mariella; Zamagni, Elena; Belotti, Angelo; Boccadoro, Mario; Gay, Francesca | |
| Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies | 2021 | Mina, Roberto; Bonello, Francesca; Petrucci, Maria Teresa; Liberati, Anna Marina; Conticello, Concetta; Ballanti, Stelvio; Musto, Pellegrino; Olivieri, Attilio; Benevolo, Giulia; Capra, Andrea; Gilestro, Milena; Galieni, Piero; Cavo, Michele; Siniscalchi, Agostina; Palumbo, Antonio; Montefusco, Vittorio; Gaidano, Gianluca; Omedé, Paola; Boccadoro, Mario; Bringhen, Sara | |
| Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents | 2020 | Mina R.; Joseph N.S.; Gay F.; Kastritis E.; Petrucci M.T.; Kaufman J.L.; Montefusco V.; Gavriatopoulou M.; Patriarca F.; Omede P.; Boise L.H.; Roussou M.; Giuliani N.; Oliva S.; Offidani M.; Belotti A.; Jaye D.L.; De Paoli L.; Terpos E.; Lonial S.; Boccadoro M.; Nooka A.K.; Dimopoulos M.A. | |
| Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study | 2019 | Kaufman J.L.; Mina R.; Jakubowiak A.J.; Zimmerman T.L.; Wolf J.J.; Lewis C.; Gleason C.; Sharp C.; Martin T.; Heffner L.T.; Nooka A.K.; Harvey R.D.; Lonial S. | |
| COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies | 2021 | Passamonti F.; Romano A.; Salvini M.; Merli F.; Porta M.G.D.; Bruna R.; Coviello E.; Romano I.; Cairoli R.; Lemoli R.; Farina F.; Venditti A.; Busca A.; Ladetto M.; Massaia M.; Pinto A.; Arcaini L.; Tafuri A.; Marchesi F.; Fracchiolla N.; Bocchia M.; Armiento D.; Candoni A.; Krampera M.; Luppi M.; Cardinali V.; Galimberti S.; Cattaneo C.; La Barbera E.O.; Mina R.; Lanza F.; Visani G.; Musto P.; Petrucci L.; Zaja F.; Grossi P.A.; Bertu L.; Pagano L.; Corradini P.; Derenzini E.; Marchetti M.; Scattolin A.M.; Corso A.; Tosi P.; Gherlinzoni F.; Passerini C.G.; Cavo M.; Fava C.; Turrini M.; Visco C.; Zappasodi P.; Merli M.; Mora B.; Vannucchi A.M. | |
| Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma | 2014 | Bringhen S.; Gay F.; Donato F.; Troia R.; Mina R.; Palumbo A. | |
| Current treatment strategies with lenalidomide in multiple myeloma and future perspectives. | 2012 | Larocca A;Cavallo F;Mina R;Boccadoro M;Palumbo A | |
| CyTOF®: A New Tool to Decipher the Immunomodulatory Activity of Daratumumab | 2019 | Castella B, Mina R, Gay F | |
| Daratumumab-Based Therapy for IgM Multiple Myeloma With Hyperviscosity Syndrome: A Case Report | 2021 | Mina R.; Bonello F.; Gay F.; Zamagni E.; Boccadoro M. | |
| Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients | 2021 | Zaccaria, Gian Maria; Bertamini, Luca; Petrucci, Maria Teresa; Offidani, Massimo; Corradini, Paolo; Capra, Andrea; Romano, Alessandra; Liberati, Anna Marina; Mannina, Donato; de Fabritiis, Paolo; Cascavilla, Nicola; Ruggeri, Marina; Mina, Roberto; Patriarca, Francesca; Benevolo, Giulia; Belotti, Angelo; Gaidano, Gianluca; Nagler, Arnon; Hájek, Roman; Spencer, Andrew; Sonneveld, Pieter; Musto, Pellegrino; Boccadoro, Mario; Gay, Francesca |